CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
R1-25 and R2-25 Pulse Oximeter Sensordevice
Likely dose
Not stated in record
Key inclusion· 2
  • Adult aged >18 years
  • Healthy status
Key exclusion· 2
  • Inability to understand study and associated risks
  • Deemed ineligible by study test personnel

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03134326
NCT03134326N/ACompleted

Rainbow R2-25 vs. R1-25 SpHb Sub-Range Performance Equivalence

Masimo Corporation·interventional·Posted Apr 28, 2017·Updated Jul 27, 2017

In Brief

A clinical study evaluating R1-25 and R2-25 Pulse Oximeter Sensor for Healthy. Completed, enrolled 21 participants across 1 site.

Detailed Summary

In this study, the concentration of hemoglobin was measured using noninvasive pulse oximeter sensors and compared against the hemoglobin measurement from the subject's blood sample under controlled conditions. Data collected in the study was in the sub-range of 12-17 g/dL in the device's 8-17 g/dL specification range. The purpose of the study was to evaluate a change in the sensor component and to assess performance equivalence in the sub-range. The performance of non-invasive hemoglobin is not uniform across the accuracy range.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 28, 2017
Enrollment StartJun 18, 2009
Primary CompletionJul 2, 2009
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 9.2 years ago

Interventions

R1-25 and R2-25 Pulse Oximeter Sensordevice